Arginine-vasopressin (AVP) has been proposed to be involved in the modulation of acid-base transporters; however, the nature of the mechanisms underlying AVP direct action on intracellular pH (pH i ) in the cortical collecting duct (CCD) is not yet clearly defined. The aim of the present study was to elucidate which are the proteins implicated in AVP modulation of pH i , as well as the receptors involved in these responses using a CCD cell line (RCCD 1 ); pH i was monitored with the fluorescent dye BCECF in basal conditions and after stimulation with basolateral 10 -8 M AVP. Specific V1-or V2-receptor antagonists were also used. RT-PCR studies demonstrated that RCCD 1 cells express V1a and V2 receptors. Functional studies showed that while V2-receptor activation induced a biphasic response (alkalinizationacidification), V1-receptor activation resulted in an intracellular acidification. The V2-mediated alkalinization phase involves the activation of basolateral NHE-1 isoform of the Na 
M AVP. Specific V1-or V2-receptor antagonists were also used. RT-PCR studies demonstrated that RCCD 1 cells express V1a and V2 receptors. Functional studies showed that while V2-receptor activation induced a biphasic response (alkalinizationacidification), V1-receptor activation resulted in an intracellular acidification. The V2-mediated alkalinization phase involves the activation of basolateral NHE-1 isoform of the Na + /H + exchanger while in the acidification phase CFTR is probably implicated. On the other hand, V1-mediated acidification was due to activation of a Cl
Introduction
In the mammalian collecting duct (CD) arginine vasopressin (AVP) plays a critical role in adjusting urine volume and composition. Although the role of AVP in regulating water permeability is well known, its effects on electrolyte transport are more complex and not fully understood [1] [2] [3] . AVP has been proposed to be involved in the modulation of many electrolyte channels or transporters, including the epithelial Na [4] [5] [6] [7] . Although some of these proteins are acid-base transporters, the nature of the mechanism underlying AVP 550 action on intracellular pH (pH i ) has not been yet clearly defined. For instance, Na + /H + exchanger (NHE) activity was shown to be either inhibited by AVP in some nephron segments or stimulated in other segments as well as in several renal cell lines [8] [9] [10] . In addition, some authors proposed that AVP modulates in a different way Na + /H + exchangers present in the basolateral (via activation) and luminal membrane (via inhibition) [8, 11] . Ganz et al. proposed that AVP also stimulates Na + -dependent and independent Cl -/HCO 3 - exchangers in mesangial cells [6] . Even more, in inner medullary collecting duct cells it was suggested that AVP stimulation of Cl -/HCO 3 -exchangers would be involved in Cl -secretion, although its activity was not evaluated [7] . In conclusion, AVP modulation of AE transporters in the CD cells is still unclear. AVP has also been postulated to modulate Cl -transport via the CFTR, a channel that directly or indirectly also provides a bicarbonate conductance [12, 13] . However its involvement in pH i response to AVP has not yet been investigated.
All these AVP actions may be regulated through two distinct types of receptors (V1 and V2) [14] . Most studies have proposed that AVP modulation of water and solute transport, when applied to the basolateral surface of the collecting duct, is mediated by V2 receptors [15] . On the other hand, V1 receptor has been implicated in distal tubule basolateral AVP stimulation of bicarbonate reabsorption [16] and in AVP luminal responses [4] . However, to date, the role of V1/V2 receptors in AVP action on pH i in the CD remains obscure.
Therefore, the aim of the present study was to elucidate the mechanisms involved in AVP modulation of pH i , as well as the receptors implicated in these responses using a rat cortical collecting duct cell line (RCCD 1 ). This cell line has previously proved to be a very useful model to achieve molecular and functional insights on "shortterm" and "long-term" regulation by AVP of ion channels such as ENaC, K + channels and CFTR [5, 12, [17] [18] [19] [20] . More recently, using this cell model, we have contributed to the understanding of the specific roles of different isoforms of the acid-base transporters NHE and AE (19, 21) . To our knowledge RCCD 1 represents an attractive model to study the effects of AVP on acid-base transporters due to its capacity to maintain both the sensitivity to AVP and the expression of H + /HCO 3 -extruders.
In the present work, pH i response to basolateral AVP was monitored using the fluorescent dye 2',7'bis (2-carboxyethyl)-5-(and-6) carboxyfluorescein (BCECF-AM) in cell monolayers grown on permeable filters, a support that provides independent and free access to both the apical and the basolateral compartments. Our studies demonstrated, for the first time, that in RCCD 1 cells AVP is able to modulate, simultaneously, different proteins involved in pH i regulation. We showed that the hormone stimulates NHE-1 and possibly CFTR via V2 receptors, as well as Cl -/HCO 3 -exchange activity through V1 receptors. 
Materials and Methods

Cell
Intracellular pH Studies
As previously reported, filters with RCCD 1 monolayers were inserted between two lucite frames and diagonally placed in a quartz cuvette, providing a separation of two fluid compartments [19] . Measurements were made with a computerized and thermoregulated (37°C) spectrofluorometer (Jasco 770, Easton, MD, USA). For the measurements, the cell monolayer was placed forming a 45° angle to the exploring beam. Fluorescence emission was monitored at 535 nm, with excitation wavelengths of 439 and 510 nm. For pH i measurements, cells were loaded with 8 µM of 2',7'bis (2-carboxyethyl)-5-(and-6) carboxyfluorescein acetoxymethyl ester (BCECF/AM, Molecular Probes, Eugene, OR, USA) during 60min at 37°C, both from the apical and basolateral baths. The ratio of the BCECF fluorescence emitted from dye-loaded cells was calibrated in terms of pH, by incubating the cells in a "high K + solution" (140 mM KCl, 4.6 mM NaCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM Hepes, 5 mM glucose) and then by permeabilizing the cells with 5 μM nigericin to balance extracellular pH (pH o ) with pH i . The pH-bathing solution was stepped between 6.6 and 8.5. The 510 / 439 ratio was linear over this pH range (r = 0.99, n = 6).
pH i was evaluated in cells bathed on each side with a control solution and after the addition of 10 -8 M AVP or vehicle (water) to the basolateral bath. In all pharmacological studies, the respective vehicles were tested.
Anion exchange activity in RCCD 1 cells was evaluated as previously reported [21] , immediately after transition from a Cl San Diego, CA. USA) and dpHi/dt was the first derivate at t = 0.
RT-PCR Assays
Total RNA from rat kidney (positive control) or RCCD 1 cells was isolated using SV total RNA Isolation System (Promega, Madison, WI, USA). Reverse transcription was performed on 2 µg of total RNA using M-MLV reverse transcriptase (Promega). RNAs were placed in 50 µl of "RT reaction buffer" containing: 1X M-MLV reverse transcriptase buffer (Promega), 0.5 µg oligo-dt primer and 10 U µl -1 RNAsin. The reaction was heated 3min at 80°C and cooled to 45°C. PCR buffer (25 µl) containing: 1X M-MLV reverse transcriptase buffer, 2.5 mM MgCl 2 , 0.4 mM dNTPs and 400 units M-MLV, was added to half of the reaction. Control experiments, in absence of the enzyme M-MLV, were performed on the remaining 25 µl. RT reaction was carried out for 1h at 45°C and stopped by heating 2min at 95°C.
PCR experiments were performed with 5 µl of the RT reaction using 25 pmol of specific primers for rat V1a, V1b and V2 (Table 1 ). An internal positive control was included in each experiment using β-actin specific primers (sense: 5' CGG AAC CGC TCA TTG CC 3'; antisense: 5' ACC CAC ACT GTG CCC ATC TA 3'). Cycling parameters were for V1a and V2: 2min at 94°C, 2min at 55°C, 2min at 72°C for one cycle and 1min at 94°C, 1min at 55°C, 1min at 72°C for 34 cycles; for V1b: 2min at 94°C, 2min at 63°C, 2min at 72°C for one cycle and 1min at 94°C, 1min at 63°C, 1min at 72°C for 34 cycles. To amplify V1b receptor products, a second PCR was performed using 5µl of the first reaction. 
Solutions and chemicals
Statistics
Results are expressed as mean ± SEM. Student's t Test for paired or unpaired data was used according to the protocol; p < 0.05 was considered a significant difference.
Results
AVP modulates steady-state pH i in RCCD 1 cells
The first set of experiments examined the effect of AVP on baseline pH i in RCCD 1 cells grown on permeable supports. Figure 1A shows that the addition of 10 -8 M basolateral AVP elicited a biphasic response in pH i : an initial transient alkalinization, followed by an acidification restoring the steady-state pH i . These effects were not observed in the presence of vehicle. AVP maximal alkalinization, calculated as the difference between baseline pH i and that obtained at the first minute (ΔpH i alk ), gave a value of 0.106 ± 0.016 pH units (n = 32). The acidification (ΔpH i acid ) was estimated as the difference between pH i values obtained at the first minute and the pH i achieved 10 min after AVP stimulation. The mean acidification was -0.097 ± 0.008 pH units (n= 32).
The putative acid-base transporters involved in these responses were then investigated. Since we have previously reported that RCCD 1 cells express two isoforms (NHE-1 and NHE-2) of the Na + /H + exchanger Table 1 . Specific rat primers used to detect the expression of AVP receptor isoforms: RT-PCR experiments were performed using specific rat primers, both in rat kidney and in RCCD 1 at the basolateral membrane [19] , we examined whether the initial alkalinization was linked to this transporter activation. Therefore, experiments were first performed in cells that were previously incubated during 10 min with 10 isoform might mediate the above-described alkalinization, we used the highly selective inhibitor HOE-694 which at low doses (1 µM) inhibits NHE-1 but not NHE-2, while at higher doses (15 µM) blocks both isoforms [22, 23] . As shown in Figure 1B M AVP. Figure 2C shows that, upon AVP stimulation, the rate of anion exchange activity was significantly increased respect to the vehicle (inset). Altogether, these results demonstrated that a Cl -/HCO 3 -exchanger is also activated by AVP.
V1a and V2 receptors are expressed in RCCD 1 cells
Although functional studies using the specific agonist dDAVP have demonstrated that RCCD 1 cells express the V2 receptor [5, 12, 17] ; V1 receptor expression has not been previously tested. Then, before determining which AVP-receptors might mediate the above-described responses, the V1/V2 receptors expression in RCCD 1 cells was evaluated by RT-PCR. Experiments were carried out with primers for the different rat AVPreceptors previously reported in the literature (V1a, V1b and V2, Table I ) [25, 26] . Assays were undertaken using total RNA extracted from RCCD 1 cells and rat kidneys (as positive controls). Figure 3 shows the results of representative RT-PCR experiments. As expected, RT-PCR of rat kidney RNA produced fragments of the proper size for all the tested receptors. On the other hand, only mRNAs for V1a (∼533 bp) and V2 (∼460 bp) are expressed in RCCD 1 cells. β-actin was used as an internal control for kidneys and RCCD 1 cells in all experiments ( Figure 3B ). These results confirm the expression of V1a and V2 receptors in RCCD 1 cells.
V1 and V2 receptors participate in AVP pH i modulation
To detect which of the above mentioned receptors expressed in RCCD 1 cells could be involved in the AVP pH i modulation response; we evaluated the effect of specific V1-or V2-receptor antagonists. In all experiments, cells were first incubated for 10 min with the antagonist and then stimulated by 10 -8 M AVP. It is important to point out that the presence of antagonists did not affect steady-state pH i , indicating no intrinsic effects (control: 7.47 ± 0.04, n=13; Anti V1: 7.45 ± 0.05, n=9; Anti V2: 7.44 ± 0.07, n=5). Figure 4A illustrates pH i time-course in the presence of AVP plus either vehicle, 10 -6 M V1-antagonist, 10 -6 M V2-antagonist or both. It can be noted that in the presence of V1-antagonist AVP induced an alkalinization followed by a slightly lower pH i recovery. In contrast, AVP incubation with V2-antagonist only elicited an acidification. Figure 4B resumes that the addition of V1-receptor antagonist did not affect the initial alkalinization. On the other hand, in the presence of a V2-receptor antagonist, the initial alkalinization was completely blunted. No additional effects were observed in the presence of both, V1 plus V2, antagonists. Moreover, the initial alkalinization was also obtained in the presence of 10 -8 M dDAVP, a specific V2-receptor agonist. Experiments using the agonist dDAVP plus HOE-693 confirmed that this effect was NHE-1 dependent (ΔpH i alk pH units: dDAVP: 0.110 ± 0.021 vs. dDAVP + HOE: -0.002 ± 0.018, n=6, p < 0.001). Together, these results confirm that the NHE1-mediated alkalinization phase above described takes place via a V2-receptor pathway.
Concerning the AVP-related acidification Figure 4C shows that, in the presence of V1-antagonist, ΔpH i acid was slightly lower than that observed in cells treated with AVP plus vehicle. A similar response was obtained activating V2-receptor with the specific agonist dDAVP; in contrast, the V2-antagonist did not affect the acidification phase. However, ΔpH i acid was completely blunted in the presence of both antagonists, which suggests that V2 receptors may also be involved in the AVPinduced acidification.
These stated results describe that a Cl -/HCO 3 -exchanger contributes to the AVP-induced acidification. In order to evaluate which receptor would be involved in this response, Cl -removal experiments were performed in the presence of the specific antagonists ( Figure 5A ).
It can be observed that the AVP-induced stimulation of Cl -/HCO 3 -anion exchanger activity was significantly blocked in the presence of V1-receptor antagonist ( Figure  5B ). In contrast, this response was not affected by V2-receptor antagonist. Moreover, V1 plus V2 antagonists elicit the same response than that observed with V1 antagonist. According to these results, it can be proposed that in RCCD 1 cells AVP stimulates a Cl -/HCO 3 -exchanger via the V1-, but not V2-, receptor pathway. However, V2-receptor could also be involved in the acidification response if another mechanism is implicated. To further investigate this hypothesis we first evaluated if CFTR is involved in the AVP induced acidification.
Previous studies (including ours in RCCD 1 cells) have shown that dDAVP stimulates chloride secretion, via CFTR, in mammalian CCD and IMCD cells [12, 27] . Even more, several authors have proposed that, besides Figure  6 A-C shows that in the presence of the V1-receptor antagonist and glibenclamide while the initial alkalinization takes place, pH i was not able to recover. In contrast, using the V2-receptor antagonist, the AVP induced acidification was not affected by glibenclamide ( Figure  6D ). These results suggest that CFTR channels may participate in the AVP-induced acidification via the V2-receptor pathway. In this study, we demonstrated that AVP stimulation, via V2-receptor, induces a biphasic response on baseline pH i (alkalinization-acidification). A number of evidences, here presented, strongly demonstrated that the alkalinization phase is a consequence of a direct activation of the isoform NHE-1 of the Na + /H + exchanger, via V2 receptor. First, the alkalinization phase was completely blunted in the presence of 1 µM HOE, a dose necessary to block NHE-1 but not NHE-2. Second, this response was mimicked with the specific V2-receptor agonist dDAVP and it was completely blunted in the presence of dDAVP plus 1 μM HOE. Finally, the alkalinization phase was not observed in the presence of V2-receptor antagonist but it was achieved with the addition of V1-receptor antagonist.
Discussion
AVP stimulates Na
The proposal that AVP stimulates NHE-1 is in agreement with previous reports in mesangial, MDCK and LLC-PK1 cells [6, 8, 9, 29] . However, Schlatter et al. reported, in clusters of principal cells of rat CCD, that NHE activity is inhibited by AVP [10] . However, in this work, because of CCD clusters conformation, apical membrane is probably mainly exposed to AVP stimulus. Conversely, we are here exclusively evaluating the effects of basolateral AVP. Exposition of RCCD 1 cells to 10 -8 M apical AVP only induces a progressive acidification ( ΔpH i : -0.032 ± 0.016 pH units 10 min after AVP addition, n=5). Therefore, we suggest that AVP activates NHE-1 via V2-receptor and this effect is only observed when the hormone is added from the basolateral bath.
V2-receptors stimulation also induces a decrease in pH i (acidification phase). This was demonstrated using the specific V2-receptor agonist dDAVP as well as specific antagonists. Even more, the herein observed acidification phase induced by AVP, via V2-receptors, was completely blocked by glibenclamide, probably indicating the participation of CFTR in this response. Previous studies (including ours in RCCD 1 3 - exchangers) which could be essential for intracellular homoeostasis maintenance. Although the potential application of these results to the physiological state is still speculative, the proposal that AVP selectively regulates different acidbase transporters may contribute to further understand the larger integrative transport functions of renal epithelia by means of studying single transport molecules.
